Impact of emotionally-charged images and trial order on downstream cognitive processing: An ERP study.

Theories of emotion-cognition interactions suggest that emotional valence can both facilitate or limit cognitive performance. One cause for the mixed findings may be the order (random versus non-random presentation) in which emotional stimuli are presented. To investigate the impact of stimuli order on cognitive control processing, EEG data were recorded as 130 undergraduate students (M age = 22.2, SD = 5.4; 79 female) completed a modified version of the AX-Continuous Performance Task in which the cue was followed by an emotionally-valenced image (positive, negative, and neutral). Specifically, the task was designed so that valenced images were presented in either a block or random order, prior to probe presentation. We examined two event-related potentials (ERPs), the N2, which reflects aspects of cognitive control, and the late positive potential (LPP), which reflects attention allocation to emotional stimuli. We assessed the impact of emotionally oriented attention (LPP) on downstream cognitive control (N2) and how this relationship might differ for a block versus random (order of emotional image) task design. Consistent with the LPP literature, we found a main effect of image valence with the negative trials showing larger LPPs than the positive and neutral trials. For N2s, we found that the negative trials were associated with smaller N2s than both the positive and neutral trials. We observed that as LPP amplitude increased, subsequent N2 amplitude was reduced, specifically for negative trials in the random design. These results suggest an emotion-related depletion of neural cognitive resources. Lastly, we found larger N2s for the block design versus the random design. Together, these results indicate the importance of paying attention to both trial order (block versus random) and within trial stimulus sequence when designing emotion induction tasks.

Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities.

BACKGROUND AND STUDY AIMS: Placing small stents in the pancreatic duct at endoscopic retrograde cholangiopancreatography reduces the risk of pancreatitis. However, this practice means that a second procedure might be required to remove the stent, and stents can also damage the duct. The aims of this study were to determine the frequency of spontaneous dislodgment and to assess the incidence of stent-induced ductal irregularities. PATIENTS AND METHODS: We performed a retrospective analysis of consecutive patients seen over a 3-year period (2001 - 2004) who had undergone placement of a 3-Fr pancreatic duct stent and in whom the fate of the stent had been documented. Radiographs were reviewed to determine stent passage at 30 days. If applicable, follow-up pancreatograms were reviewed to assess for stent-induced ductal abnormalities. Statistical analysis was performed using chi-squared and Fisher's exact tests for proportions, and 95 % binomial confidence intervals (CI) were calculated. RESULTS: Records for 125 consecutive patients who had had 3-Fr pancreatic stents placed were reviewed. The stents had passed spontaneously within 30 days in 110/125 patients (88 %). In the remaining 15 patients (12 %, 95 % CI 6.9 % - 19 %), the stents were still present on follow-up radiographs after a median time of 36 days, (range 31 - 116 days). Stent length, pancreatic sphincterotomy, and pancreas divisum had no effect on the likelihood of spontaneous passage. No stent-induced ductal irregularities were observed. CONCLUSIONS: Nearly 90 % of prophylactic 3-Fr pancreatic duct stents pass spontaneously within 30 days, and these stents were not observed to induce changes in the pancreatic duct.

Pancreatitis Partners: a sharing and educational support group.

A team in a digestive disease center at a 550-bed tertiary care center in the Southeast created an interactive, educational patient and family support group for people with pancreatitis. No previous support groups for this population could be located in the United States by us, although pancreatitis is a disease that may progress to include chronic pain, frequent hospitalizations or emergency room visits, narcotic dependence, and depression. The article describes and illustrates the need, planning, inception, implementation, evaluation, and re-visioning of an outpatient support and education group for people affected by pancreatitis. The group uses a partnership model as a basis for helping empower patients and their family members to have more understanding of, adaption to, and say in the treatment choices and responsibility for managing symptoms of their chronic illness. Facilitated by a multidisciplinary team, this is the first group of its kind in the United States and was enthusiastically received by those who participated. Group members were surveyed at the conclusion of the first ten group sessions. Results of this survey and modification to the group format and expanded outreach plans to people affected by pancreatitis are outlined and discussed.